Earnings Feed
Start Free
Home/Filings/4/0000914190-18-000400
4//SEC Filing

GOLDSTEIN ALLAN L 4

Accession 0000914190-18-000400

CIK 0000707511other
View on SEC.govCompany Profile

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 5:26 PM ET

Size

20.7 KB

Accession

0000914190-18-000400

Insider Transaction Report

Form 4
Period: 2018-09-11
REGENERX BIOPHARMACEUTICALS INCRGRX
GOLDSTEIN ALLAN L
Director
Transactions
  • Conversion

    Convertible Promissory Note (right to buy)

    2018-09-11−229,803→ 0 total
    Exercise: $0.06From: 2013-09-12Exp: 2018-09-11→ Common Stock (229,803 underlying)
  • Conversion

    Common Stock

    2018-09-11$0.06/sh+229,803$13,788→ 1,731,881 total
Holdings

  • Stock Option (right to buy)

    Exercise: $0.57Exp: 2019-04-10→ Common Stock (71,942 underlying)
    71,942

  • Stock Option (right to buy)

    Exercise: $0.14Exp: 2019-01-24→ Common Stock (300,000 underlying)
    300,000

  • Stock Option (right to buy)

    Exercise: $0.21Exp: 2021-03-25→ Common Stock (450,000 underlying)
    450,000

  • Stock Option (right to buy)

    Exercise: $0.28Exp: 2027-09-01→ Common Stock (150,000 underlying)
    150,000

  • Convertible Promissory Note (right to buy)

    Exercise: $0.06From: 2014-01-07Exp: 2019-01-06→ Common Stock (166,667 underlying)

  • Stock Option (right to buy)

    Exercise: $0.16Exp: 2018-12-02→ Common Stock (80,135 underlying)
    80,135

  • Stock Option (right to buy)

    Exercise: $0.16Exp: 2019-04-03→ Common Stock (35,000 underlying)
    35,000

  • Stock Option (right to buy)

    Exercise: $0.36Exp: 2022-06-30→ Common Stock (250,000 underlying)
    250,000

  • Stock Option (right to buy)

    Exercise: $0.64Exp: 2023-03-16→ Common Stock (200,000 underlying)
    200,000

  • Stock Option (right to buy)

    Exercise: $0.21Exp: 2028-07-17→ Common Stock (250,000 underlying)
    250,000
Footnotes (6)
  • [F1]The Convertible Promissory Note in the principal amount of $11,000 accrued $2,788.19 in interest and both principal and interest were converted into 229,803 shares of common stock at a conversion price of $0.06 per share.
  • [F2]Represents the shares of common stock issuable upon conversion of the Convertible Promissory Note.
  • [F3]100% vested.
  • [F4]50,000 shares vest on each of 3/16/16, 3/16/17, 3/16/18 and 3/16/19.
  • [F5]37,500 shares vest on each of 9/1/17, 9/1/18, 9/1/19 and 9/1/20.
  • [F6]62,500 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.

Documents

1 file

Issuer

REGENERX BIOPHARMACEUTICALS INC

CIK 0000707511

→
Entity typeother

Related Parties

1
  • filerCIK 0000905390

Filing Metadata

Form type
4
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 5:26 PM ET
Size
20.7 KB
View on SEC.gov